SCHEMBL366345

SCHEMBL366345

BC(C)(SC(C)(C)C)SC(C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL400906 0.71
SCHEMBL10456430 0.67
Fluoride SCHEMBL775786 0.67
SCHEMBL3980722 0.67
SCHEMBL30999502 0.67
Methyl Alcohol SCHEMBL11765545 0.64 NOS1 (0.32)
SCHEMBL5315595 0.64 TSHR (0.33)
SCHEMBL10172359 0.59
SCHEMBL257782 0.59
SCHEMBL8283201 0.59

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2593429-A1 PROCESS FOR PREPARING A BIPHENYL-2-YLCARBAMIC ACID Theravance, Inc. (US) 2013-05-22 EP disclosed
WO-2012009166-A1 PROCESS FOR PREPARING A BIPHENYL-2-YLCARBAMIC ACID THERAVANCE, INC. (US) 2012-01-19 WO disclosed
EP-2358674-A1 Process for preparing 4-[2-(2-fluorophenoxymethyl)phenyl¨]iperidine compounds Theravance, Inc. (US) 2011-08-24 EP disclosed
WO-2010056938-A1 PROCESS FOR PREPARING 4-[2-(2-FLUOROPHENOXYMETHYL)PHENYL]PIPERIDINE COMPOUNDS THERAVANCE, INC. (US) 2010-05-20 WO disclosed